As filed with the Securities and Exchange Commission on April 21, 2023 Registration No. 333- UNITED STATES SECURITIES AND...
0001621221false--12-3100016212212023-04-212023-04-21iso4217:USDxbrli:sharesiso4217:USDxbrli:shares UNITED STATESSECURITIES AND EXCHANGE...
0001621221false--12-31FY20220.001416667000005000000028556882820068163510938100029560100000069.4500.000.000.0000.00000031390900000.0000.00P8Y10M24D0...
SOLANA BEACH, Calif., March 31, 2023 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq:ARTL), a...
0001621221false00016212212023-03-102023-03-10iso4217:USDxbrli:sharesiso4217:USDxbrli:shares UNITED STATESSECURITIES AND EXCHANGE COMMISSION...
SOLANA BEACH, Calif., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a...
CEO Gregory Gorgas to discuss developments related to the Company’s Cancer Appetite Recovery Study (CAReS...
In a report released yesterday, Jason McCarthy from Maxim Group maintained a Buy rating on Artelo Biosciences (ARTL - Research Report), with a...
In a report released today, Michael Higgins from Ladenburg Thalmann & Co. maintained a Buy rating on Artelo Biosciences (ARTL - Research Report...
0001621221false--12-31Q320220.0014166670000.0015000000028556882820068300000148800012347000104860001165000134700002000000.02859184158400016212212022...
Enrollment of Phase 2a CAReS Study Expected to Commence Near Year-End $19.5 Million in Cash and Investments as...
SOLANA BEACH, Calif., Sept. 22, 2022 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a...
SOLANA BEACH, Calif., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a...
0001621221false00016212212022-08-242022-08-24iso4217:USDxbrli:sharesiso4217:USDxbrli:shares UNITED STATESSECURITIES AND EXCHANGE...
H.C. Wainwright analyst Vernon Bernardino reiterated a Buy rating on Artelo Biosciences (ARTL - Research Report) today and set a price target of...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.